<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40903083</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>03</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Safety and efficacy of remote ischaemic preconditioning in diabetic kidney disease: a pilot randomised, parallel-arm, sham-controlled trial protocol.</ArticleTitle><Pagination><StartPage>e096851</StartPage><MedlinePgn>e096851</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e096851</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2024-096851</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Diabetic kidney disease (DKD), characterised by rapid progression and poor prognosis, accounts for approximately 50% of all end-stage renal disease. Remote ischaemic preconditioning (RIP) can reduce the impact of subsequent fatal ischaemic events through brief episodes of ischaemia remote from a target organ. Therefore, we aim to determine whether RIP can slow the renal failure progression in patients with DKD.</AbstractText><AbstractText Label="METHODS AND ANALYSIS" NlmCategory="METHODS">This is a pilot randomised, parallel-arm, sham-controlled trial of 60 participants with stable DKD (chronic kidney disease stages 3-4). Participants will be randomly assigned to the intervention or control group undergoing one daily RIP or sham RIP for 3 months, with a subsequent 6-month follow-up period. The primary study outcome is the incidence of end-stage kidney disease. The secondary outcomes include changes in biomarkers of chronic kidney disease progression, cardiovascular outcomes, rates of renal failure requiring dialysis or transplantation, tolerability rates and adverse event incidence.</AbstractText><AbstractText Label="ETHICS AND DISSEMINATION" NlmCategory="BACKGROUND">This study has been approved by the Ethics Committee of Xuanwu Hospital of Capital Medical University (no. [2020]154). Our research findings will be published in peer-reviewed journal articles and conference presentations.</AbstractText><AbstractText Label="TRIAL REGISTRATION NUMBER" NlmCategory="BACKGROUND">NCT06654921.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Lanjing</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2164-5396</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jia</LastName><ForeName>Linpei</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Shuangfeng</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren</LastName><ForeName>Changhong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Yao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Wenbo</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Xunming</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China lisijie@xwh.ccmu.edu.cn jixm@ccmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Key Laboratory of Hypoxic Conditioning Translational Medicine, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuro Cardio Vascular Diseases Center, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Sijie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Xuanwu Hospital Capital Medical University, Beijing, China lisijie@xwh.ccmu.edu.cn jixm@ccmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Beijing Institute of Brain Disorders, Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuro Cardio Vascular Diseases Center, Xuanwu Hospital Capital Medical University, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT06654921</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003928" MajorTopicYN="Y">Diabetic Nephropathies</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019194" MajorTopicYN="Y">Ischemic Preconditioning</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007676" MajorTopicYN="Y">Kidney Failure, Chronic</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Clinical Protocols</Keyword><Keyword MajorTopicYN="N">Diabetic nephropathy &amp; vascular disease</Keyword><Keyword MajorTopicYN="N">Randomized Controlled Trial</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>4</Day><Hour>0</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>4</Day><Hour>0</Hour><Minute>36</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>3</Day><Hour>20</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40903083</ArticleId><ArticleId IdType="pmc">PMC12410602</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2024-096851</ArticleId><ArticleId IdType="pii">bmjopen-2024-096851</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Tuttle KR, Bakris GL, Bilous RW, et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Diabetes Care. 2014;37:2864&#x2013;83. doi: 10.2337/dc14-1296.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc14-1296</ArticleId><ArticleId IdType="pmc">PMC4170131</ArticleId><ArticleId IdType="pubmed">25249672</ArticleId></ArticleIdList></Reference><Reference><Citation>Scilletta S, Di Marco M, Miano N, et al. Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk. Biomolecules. 2023;13:752. doi: 10.3390/biom13050752.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom13050752</ArticleId><ArticleId IdType="pmc">PMC10216614</ArticleId><ArticleId IdType="pubmed">37238622</ArticleId></ArticleIdList></Reference><Reference><Citation>Gervasini G. Recent Advances and Remaining Challenges in the Management of Diabetic Kidney Disease. J Clin Med. 2023;12:2759. doi: 10.3390/jcm12082759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12082759</ArticleId><ArticleId IdType="pmc">PMC10142336</ArticleId><ArticleId IdType="pubmed">37109096</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren S-C, Mao N, Yi S, et al. Vascular Calcification in Chronic Kidney Disease: An Update and Perspective. Aging Dis. 2022;13:673&#x2013;97. doi: 10.14336/AD.2021.1024.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.1024</ArticleId><ArticleId IdType="pmc">PMC9116919</ArticleId><ArticleId IdType="pubmed">35656113</ArticleId></ArticleIdList></Reference><Reference><Citation>Pender D, McGowan E, McVeigh JG, et al. The Effects of Intradialytic Exercise on Key Indices of Sarcopenia in Patients With End-stage Renal Disease: A Systematic Review of Randomized Controlled Trials. Arch Rehabil Res Clin Transl . 2023;5:100252. doi: 10.1016/j.arrct.2022.100252.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arrct.2022.100252</ArticleId><ArticleId IdType="pmc">PMC10036234</ArticleId><ArticleId IdType="pubmed">36968168</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Su F, Zhang L, et al. Identifying Potential Diagnostic Genes for Diabetic Nephropathy Based on Hypoxia and Immune Status. J Inflamm Res. 2021;14:6871&#x2013;91. doi: 10.2147/JIR.S341032.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JIR.S341032</ArticleId><ArticleId IdType="pmc">PMC8684433</ArticleId><ArticleId IdType="pubmed">34934337</ArticleId></ArticleIdList></Reference><Reference><Citation>Blazek O, Bakris GL. Slowing the Progression of Diabetic Kidney Disease. Cells. 2023;12:1975. doi: 10.3390/cells12151975.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12151975</ArticleId><ArticleId IdType="pmc">PMC10417620</ArticleId><ArticleId IdType="pubmed">37566054</ArticleId></ArticleIdList></Reference><Reference><Citation>Chao CT, Chiang CK, Hung KY. Extracellular MicroRNAs as Potential Biomarkers for Frail Kidney Phenotype: Progresses and Precautions. Aging Dis. 2023 doi: 10.14336/AD.2023.0818.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2023.0818</ArticleId><ArticleId IdType="pmc">PMC11272190</ArticleId><ArticleId IdType="pubmed">37611904</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberger C, Khamaisi M, Abassi Z, et al. Adaptation to hypoxia in the diabetic rat kidney. Kidney Int. 2008;73:34&#x2013;42. doi: 10.1038/sj.ki.5002567.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.ki.5002567</ArticleId><ArticleId IdType="pubmed">17914354</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Wei Q, Guo C, et al. Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney Disease. IJMS. 2017;18:950. doi: 10.3390/ijms18050950.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18050950</ArticleId><ArticleId IdType="pmc">PMC5454863</ArticleId><ArticleId IdType="pubmed">28468297</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zhang Y, Chi P. Pirfenidone suppresses TGF&#x2011;&#x3b2;1&#x2011;induced human intestinal fibroblasts activities by regulating proliferation and apoptosis via the inhibition of the Smad and PI3K/AKT signaling pathway. Mol Med Report. 2018;18:3907&#x2013;13. doi: 10.3892/mmr.2018.9423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2018.9423</ArticleId><ArticleId IdType="pmc">PMC6131636</ArticleId><ArticleId IdType="pubmed">30152848</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanigut AM, Pana C, Enciu M, et al. Hypoxia-Inducible Factors and Diabetic Kidney Disease-How Deep Can We Go? Int J Mol Sci. 2022;23:10413. doi: 10.3390/ijms231810413.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms231810413</ArticleId><ArticleId IdType="pmc">PMC9499602</ArticleId><ArticleId IdType="pubmed">36142323</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren C, Li N, Xu J, et al. Hypoxic Conditioning: A Potential Perioperative Strategy to Reduce Abdominal Aortic Occlusion-Related Injury in Mouse Proximal and Distal Organs. Aging Dis. 2024;15:2863&#x2013;79. doi: 10.14336/AD.2024.0121.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2024.0121</ArticleId><ArticleId IdType="pmc">PMC11567254</ArticleId><ArticleId IdType="pubmed">38300647</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Hausenloy DJ, Hess DC, et al. Remote Ischemic Conditioning: Challenges and Opportunities. Stroke. 2023;54:2204&#x2013;7. doi: 10.1161/STROKEAHA.123.043279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.123.043279</ArticleId><ArticleId IdType="pubmed">37417240</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W, Meng R, Ma C, et al. Safety and Efficacy of Remote Ischemic Preconditioning in Patients With Severe Carotid Artery Stenosis Before Carotid Artery Stenting: A Proof-of-Concept, Randomized Controlled Trial. Circulation. 2017;135:1325&#x2013;35. doi: 10.1161/CIRCULATIONAHA.116.024807.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.024807</ArticleId><ArticleId IdType="pmc">PMC5802341</ArticleId><ArticleId IdType="pubmed">28174194</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Meng R, Song H, et al. Remote Ischemic Conditioning May Improve Outcomes of Patients With Cerebral Small-Vessel Disease. Stroke. 2017;48:3064&#x2013;72. doi: 10.1161/STROKEAHA.117.017691.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.117.017691</ArticleId><ArticleId IdType="pubmed">29042490</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, Ann SH, Chung HC, et al. Remote ischemic preconditioning in hemodialysis: a pilot study. Heart Vessels. 2014;29:58&#x2013;64. doi: 10.1007/s00380-013-0329-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00380-013-0329-y</ArticleId><ArticleId IdType="pubmed">23532306</ArticleId></ArticleIdList></Reference><Reference><Citation>Hariri G, Collet L, Duarte L, et al. Prevention of cardiac surgery-associated acute kidney injury: a systematic review and meta-analysis of non-pharmacological interventions. Crit Care. 2023;27:354. doi: 10.1186/s13054-023-04640-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04640-1</ArticleId><ArticleId IdType="pmc">PMC10498585</ArticleId><ArticleId IdType="pubmed">37700297</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Xing X, Wang L, et al. Remote ischemic conditioning reduces adverse events in patients with acute ischemic stroke complicating acute myocardial infarction: a randomized controlled trial. Crit Care. 2024;28:5. doi: 10.1186/s13054-023-04786-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-023-04786-y</ArticleId><ArticleId IdType="pmc">PMC10759604</ArticleId><ArticleId IdType="pubmed">38167175</ArticleId></ArticleIdList></Reference><Reference><Citation>Julious SA. Sample size of 12 per group rule of thumb for a pilot study. Pharm Stat. 2005;4:287&#x2013;91. doi: 10.1002/pst.185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pst.185</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne RH. On the use of a pilot sample for sample size determination. Stat Med. 1995;14:1933&#x2013;40. doi: 10.1002/sim.4780141709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sim.4780141709</ArticleId><ArticleId IdType="pubmed">8532986</ArticleId></ArticleIdList></Reference><Reference><Citation>Estrada J, Armanious I, Perri D, et al. Cuff leak test and airway obstruction in mechanically ventilated ICU patients (COSMIC): a pilot feasibility randomized controlled trial protocol. BMJ Open . 2025;15:e096053. doi: 10.1136/bmjopen-2024-096053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2024-096053</ArticleId><ArticleId IdType="pmc">PMC12182161</ArticleId><ArticleId IdType="pubmed">40537229</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. Fourth Universal Definition of Myocardial Infarction (2018) J Am Coll Cardiol. 2018;72:2231&#x2013;64. doi: 10.1016/j.jacc.2018.08.1038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2018.08.1038</ArticleId><ArticleId IdType="pubmed">30153967</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemphill JC, 3rd, Greenberg SM, Anderson CS, et al. Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46:2032&#x2013;60. doi: 10.1161/STR.0000000000000069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000069</ArticleId><ArticleId IdType="pubmed">26022637</ArticleId></ArticleIdList></Reference><Reference><Citation>Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50:e344&#x2013;418. doi: 10.1161/STR.0000000000000211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STR.0000000000000211</ArticleId><ArticleId IdType="pubmed">31662037</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarbock A, Schmidt C, Van Aken H, et al. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac surgery: a randomized clinical trial. JAMA. 2015;313:2133&#x2013;41. doi: 10.1001/jama.2015.4189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.4189</ArticleId><ArticleId IdType="pubmed">26024502</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Wills M, Li F, et al. Remote ischemic conditioning with exercise (RICE) promotes functional rehabilitation following ischemic stroke. Neurol Res. 2021;43:874&#x2013;83. doi: 10.1080/01616412.2021.1939489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01616412.2021.1939489</ArticleId><ArticleId IdType="pubmed">34151756</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Wang Y, Ji X. Immune and inflammatory mechanism of remote ischemic conditioning: A narrative review. Brain Circ. 2023;9:77&#x2013;87. doi: 10.4103/bc.bc_57_22.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/bc.bc_57_22</ArticleId><ArticleId IdType="pmc">PMC10419737</ArticleId><ArticleId IdType="pubmed">37576576</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang B, Wang X, Ma J, et al. Remote ischemic conditioning after stroke: Research progress in clinical study. CNS Neurosci Ther. 2024;30:e14507. doi: 10.1111/cns.14507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.14507</ArticleId><ArticleId IdType="pmc">PMC11017418</ArticleId><ArticleId IdType="pubmed">37927203</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao B, Wang H, Zhang C, et al. Remote Ischemic Postconditioning (RIPC) of the Upper Arm Results in Protection from Cardiac Ischemia-Reperfusion Injury Following Primary Percutaneous Coronary Intervention (PCI) for Acute ST-Segment Elevation Myocardial Infarction (STEMI) Med Sci Monit. 2018;24:1017&#x2013;26. doi: 10.12659/msm.908247.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.908247</ArticleId><ArticleId IdType="pmc">PMC5827698</ArticleId><ArticleId IdType="pubmed">29456238</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J, Liu S, Jia P, et al. Protection of remote ischemic preconditioning against acute kidney injury: a systematic review and meta-analysis. Crit Care. 2016;20:111. doi: 10.1186/s13054-016-1272-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1272-y</ArticleId><ArticleId IdType="pmc">PMC4837562</ArticleId><ArticleId IdType="pubmed">27095379</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Y-Q, Feng X-M, Shan X-S, et al. Remote Ischemic Preconditioning Reduces Acute Kidney Injury After Cardiac Surgery: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Anesth Analg. 2022;134:592&#x2013;605. doi: 10.1213/ANE.0000000000005804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1213/ANE.0000000000005804</ArticleId><ArticleId IdType="pubmed">34748518</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung J, Hur M, Cho H, et al. The Effect of Remote Ischemic Preconditioning on Serum Creatinine in Patients Undergoing Partial Nephrectomy: A Randomized Controlled Trial. J Clin Med. 2021;10:1636. doi: 10.3390/jcm10081636.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10081636</ArticleId><ArticleId IdType="pmc">PMC8069991</ArticleId><ArticleId IdType="pubmed">33921503</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan Y, Liu J, Gu Y, et al. Effects of Hypoxia on Cerebral Microvascular Angiogenesis: Benefits or Damages? Aging Dis. 2023;14:370&#x2013;85. doi: 10.14336/AD.2022.0902.</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2022.0902</ArticleId><ArticleId IdType="pmc">PMC10017152</ArticleId><ArticleId IdType="pubmed">37008044</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossaint J, Meersch M, Thomas K, et al. Remote ischemic preconditioning causes transient cell cycle arrest and renal protection by a NF-&#x3ba;B-dependent Sema5B pathway. JCI Insight. 2022;7:e158523. doi: 10.1172/jci.insight.158523.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158523</ArticleId><ArticleId IdType="pmc">PMC9431690</ArticleId><ArticleId IdType="pubmed">35727636</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou C, Liu J, Ge Y, et al. Remote Ischemic Preconditioning Ameliorates Renal Fibrosis After Ischemia-Reperfusion Injury via Transforming Growth Factor beta1 (TGF-&#x3b2;1) Signalling Pathway in Rats. Med Sci Monit. 2020;26:e919185. doi: 10.12659/MSM.919185.</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/MSM.919185</ArticleId><ArticleId IdType="pmc">PMC7020740</ArticleId><ArticleId IdType="pubmed">32024811</ArticleId></ArticleIdList></Reference><Reference><Citation>Meersch M, K&#xfc;llmar M, Pavenst&#xe4;dt H, et al. Effects of Different Doses of Remote Ischemic Preconditioning on Kidney Damage Among Patients Undergoing Cardiac Surgery: A Single-Center Mechanistic Randomized Controlled Trial. Crit Care Med. 2020;48:e690&#x2013;7. doi: 10.1097/CCM.0000000000004415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004415</ArticleId><ArticleId IdType="pubmed">32697510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou C, Lan J, Lin Y, et al. Chronic remote ischaemic conditioning in patients with symptomatic intracranial atherosclerotic stenosis (the RICA trial): a multicentre, randomised, double-blind sham-controlled trial in China. Lancet Neurol. 2022;21:1089&#x2013;98. doi: 10.1016/S1474-4422(22)00335-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(22)00335-0</ArticleId><ArticleId IdType="pubmed">36354026</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>